respiratory
Asthma

GINA: time to take mild asthma seriously

In a major change to the management of patients with mild asthma, the Global Initiative for Asthma (GINA) has recommended against starting any patients with asthma on short-acting β2 agonist (SABA) relievers alone. Instead, GINA recommends that all adults and...

In a major change to the management of patients with mild asthma, the Global Initiative for Asthma (GINA) has recommended...

Read more
Asthma

Single ICS-LABA inhaler backed for mild asthma

A single inhaler containing long-acting beta-2 agonist (LABA) and inhaled corticosteroid (ICS) might be the first step in mild asthma treatment instead of a short-acting beta agonist (SABA) for as-needed reliever therapy, a major study has shown. Findings from the ...

A single inhaler containing long-acting beta-2 agonist (LABA) and inhaled corticosteroid (ICS) might be the first step in mild asthma...
Uncategorized

Specialist earnings – who are the winners & losers?

Incomes of rheumatologists and dermatologists have surged in recent years while endocrinologists and cardiologists have seen a decline in earnings, a new report shows. After adjusting for inflation, the majority of specialties experienced a real increase in hourly earnings between 2013...

Incomes of rheumatologists and dermatologists have surged in recent years while endocrinologists and cardiologists have seen a decline in earnings,...
COPD

Eosinophil-guided therapy reduces steroids in COPD exacerbations

Blood eosinophil counts could be used to guide reductions in systemic corticosteroid dosing in patients with acute exacerbations of COPD without compromising outcomes, a Danish study has shown. A randomised, open-label trial in 358 patients hospitalised with acute exacerbations showed...

Blood eosinophil counts could be used to guide reductions in systemic corticosteroid dosing in patients with acute exacerbations of COPD...